You are here

Longboard Pharmaceuticals

Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in

Pharma Voice

Thu, 11/7/24 - 11:12 am

Vertex Pharmacuticals

Alpine Immune Sciences

Mariana Oncology

Fusion Pharmaceuticals

Longboard Pharmaceuticals

Aliada Therapeutics

Lundbeck signs $2.5B check for Longboard, seeing blockbuster potential in epilepsy med

Fierce Biotech

Mon, 10/14/24 - 10:10 am

Longboard Pharmaceuticals

After a slow week, the IPO train is back up and running as 3 more biotechs hop aboard

Endpoints

Mon, 02/22/21 - 11:45 pm

Prometheus Biosciences

Longboard Pharmaceuticals

Gain Therapeutics